Prognostic factors | ADC (× 10−3 mm2 s−1) (mean ± SD) | Univariate analysis (P value) | Correlation coefficient | ||
---|---|---|---|---|---|
r | P value | ||||
Tumor size | ≤ 4 cm > 4 cm | 1.3 ± 0.2 1.6 ± 0.2 | 0.001* | 0.48 | 0.00* |
Sex | Male Female | 1.4 ± 0.2 1.6 ± 0.2 | 0.05 | 0.28 | 0.05* |
Tissue component | Solid Mixed (cystic/necrotic) | 1.4 ± 0.2 1.6 ± 0.1 | 0.005* | − 0.4 | 0.004* |
Unenhanced T1 | Hypointense Isointense | 1.6 ± 0.2 1.4 ± 0.2 | 0.001* | − 0.46 | 0.001* |
Histopathology | Clear RCC Non-clear RCC | 1.5 ± 0.2 1.6 ± 0.2 | 0.1 | 0.22 | 0.13 |
Growth pattern | Infiltrative Cortical | 1.4 ± 0.2 1.6 ± 0.2 | 0.02* | − 0.3 | 0.01* |
Clinical stage | Low-stage (1 and II) High-stage (III and IV) | 1.6 ± 0.2 1.4 ± 0.2 | 0.01* | − 0.4 | 0.01* |
Lymph node metastasis | Yes No | 1.4 ± 0.2 1.6 ± 0.2 | 0.01* | − 0.4 | 0.01* |
Tumor grade | I II III IV | 1.6 ± 0.2 1.6 ± 0.1 1.5 ± 0.3 1.3 ± 0.1 | 0.03* | − 0.4 | 0.004* |